IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
107 hedge funds and large institutions have $1.52B invested in IGM Biosciences in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.85% more ownership
Funds ownership: 60.54% → 67.39% (+6.9%)
0% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 32
84% less call options, than puts
Call options by funds: $5.37M | Put options by funds: $33.5M
Holders
107
Holding in Top 10
3
Calls
$5.37M
Puts
$33.5M
Top Buyers
| 1 | +$45.1M | |
| 2 | +$40.7M | |
| 3 | +$39.7M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$33.1M |
| 5 |
BlackRock
New York
|
+$23.5M |
Top Sellers
| 1 | -$30.3M | |
| 2 | -$17.5M | |
| 3 | -$7.37M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.08M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.96M |